AGILYSYS INC (AGYS) Stock Fundamental Analysis

NASDAQ:AGYS • US00847J1051

72.17 USD
-1.18 (-1.61%)
At close: Feb 27, 2026
72.1624 USD
-0.01 (-0.01%)
After Hours: 2/27/2026, 8:00:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to AGYS. AGYS was compared to 276 industry peers in the Software industry. While AGYS has a great profitability rating, there are some minor concerns on its financial health. AGYS is valued quite expensively, but it does show have an excellent growth rating. These ratings could make AGYS a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year AGYS was profitable.
  • In the past year AGYS had a positive cash flow from operations.
  • Of the past 5 years AGYS 4 years were profitable.
  • In the past 5 years AGYS always reported a positive cash flow from operatings.
AGYS Yearly Net Income VS EBIT VS OCF VS FCFAGYS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M 60M 80M

1.2 Ratios

  • AGYS's Return On Assets of 6.40% is fine compared to the rest of the industry. AGYS outperforms 76.45% of its industry peers.
  • AGYS's Return On Equity of 9.72% is fine compared to the rest of the industry. AGYS outperforms 73.91% of its industry peers.
  • AGYS has a Return On Invested Capital of 7.91%. This is amongst the best in the industry. AGYS outperforms 80.07% of its industry peers.
  • AGYS had an Average Return On Invested Capital over the past 3 years of 7.16%. This is below the industry average of 10.73%.
  • The 3 year average ROIC (7.16%) for AGYS is below the current ROIC(7.91%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.4%
ROE 9.72%
ROIC 7.91%
ROA(3y)11.61%
ROA(5y)4.91%
ROE(3y)17.82%
ROE(5y)7.29%
ROIC(3y)7.16%
ROIC(5y)N/A
AGYS Yearly ROA, ROE, ROICAGYS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40

1.3 Margins

  • The Profit Margin of AGYS (9.79%) is better than 72.83% of its industry peers.
  • AGYS's Profit Margin has improved in the last couple of years.
  • With a decent Operating Margin value of 9.71%, AGYS is doing good in the industry, outperforming 76.09% of the companies in the same industry.
  • In the last couple of years the Operating Margin of AGYS has grown nicely.
  • AGYS has a Gross Margin of 61.67%. This is in the lower half of the industry: AGYS underperforms 60.51% of its industry peers.
  • AGYS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 9.71%
PM (TTM) 9.79%
GM 61.67%
OM growth 3Y22.98%
OM growth 5YN/A
PM growth 3Y43.88%
PM growth 5YN/A
GM growth 3Y-0.01%
GM growth 5Y4.37%
AGYS Yearly Profit, Operating, Gross MarginsAGYS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AGYS is destroying value.
  • The number of shares outstanding for AGYS has been increased compared to 1 year ago.
  • The number of shares outstanding for AGYS has been increased compared to 5 years ago.
  • AGYS has a worse debt/assets ratio than last year.
AGYS Yearly Shares OutstandingAGYS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
AGYS Yearly Total Debt VS Total AssetsAGYS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

2.2 Solvency

  • An Altman-Z score of 9.03 indicates that AGYS is not in any danger for bankruptcy at the moment.
  • AGYS's Altman-Z score of 9.03 is amongst the best of the industry. AGYS outperforms 91.30% of its industry peers.
  • There is no outstanding debt for AGYS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 9.03
ROIC/WACC0.73
WACC10.91%
AGYS Yearly LT Debt VS Equity VS FCFAGYS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M 200M 250M

2.3 Liquidity

  • AGYS has a Current Ratio of 1.31. This is a normal value and indicates that AGYS is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of AGYS (1.31) is worse than 61.59% of its industry peers.
  • A Quick Ratio of 1.25 indicates that AGYS should not have too much problems paying its short term obligations.
  • With a Quick ratio value of 1.25, AGYS is not doing good in the industry: 64.13% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 1.25
AGYS Yearly Current Assets VS Current LiabilitesAGYS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

9

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 26.12% over the past year.
  • The Earnings Per Share has been growing by 47.96% on average over the past years. This is a very strong growth
  • The Revenue has grown by 17.86% in the past year. This is quite good.
  • The Revenue has been growing by 11.38% on average over the past years. This is quite good.
EPS 1Y (TTM)26.12%
EPS 3Y23.91%
EPS 5Y47.96%
EPS Q2Q%10.53%
Revenue 1Y (TTM)17.86%
Revenue growth 3Y19.23%
Revenue growth 5Y11.38%
Sales Q2Q%15.57%

3.2 Future

  • The Earnings Per Share is expected to grow by 21.38% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, AGYS will show a very strong growth in Revenue. The Revenue will grow by 21.76% on average per year.
EPS Next Y6.32%
EPS Next 2Y18.73%
EPS Next 3Y21.38%
EPS Next 5YN/A
Revenue Next Year16.54%
Revenue Next 2Y15.44%
Revenue Next 3Y15.02%
Revenue Next 5Y21.76%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AGYS Yearly Revenue VS EstimatesAGYS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M
AGYS Yearly EPS VS EstimatesAGYS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 2

More info and screens

Find the best growth stocksShow best growing peers

3

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 42.70, the valuation of AGYS can be described as expensive.
  • The rest of the industry has a similar Price/Earnings ratio as AGYS.
  • Compared to an average S&P500 Price/Earnings ratio of 27.07, AGYS is valued quite expensively.
  • The Price/Forward Earnings ratio is 32.82, which means the current valuation is very expensive for AGYS.
  • The rest of the industry has a similar Price/Forward Earnings ratio as AGYS.
  • AGYS is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 28.05, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 42.7
Fwd PE 32.82
AGYS Price Earnings VS Forward Price EarningsAGYS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as AGYS.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as AGYS.
Industry RankSector Rank
P/FCF 34.27
EV/EBITDA 48.25
AGYS Per share dataAGYS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • AGYS has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as AGYS's earnings are expected to grow with 21.38% in the coming years.
PEG (NY)6.76
PEG (5Y)0.89
EPS Next 2Y18.73%
EPS Next 3Y21.38%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • AGYS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AGILYSYS INC

NASDAQ:AGYS (2/27/2026, 8:00:00 PM)

After market: 72.1624 -0.01 (-0.01%)

72.17

-1.18 (-1.61%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)01-26
Earnings (Next)05-18
Inst Owners106.42%
Inst Owner Change-0.61%
Ins Owners4.27%
Ins Owner Change-0.22%
Market Cap2.03B
Revenue(TTM)310.64M
Net Income(TTM)30.42M
Analysts81.43
Price Target139.11 (92.75%)
Short Float %5.65%
Short Ratio5.6
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.76%
Min EPS beat(2)-9.64%
Max EPS beat(2)2.12%
EPS beat(4)2
Avg EPS beat(4)16.71%
Min EPS beat(4)-10.75%
Max EPS beat(4)85.11%
EPS beat(8)6
Avg EPS beat(8)14.3%
EPS beat(12)10
Avg EPS beat(12)18.27%
EPS beat(16)14
Avg EPS beat(16)20.42%
Revenue beat(2)1
Avg Revenue beat(2)0.44%
Min Revenue beat(2)-0.27%
Max Revenue beat(2)1.14%
Revenue beat(4)3
Avg Revenue beat(4)0.98%
Min Revenue beat(4)-0.27%
Max Revenue beat(4)1.95%
Revenue beat(8)3
Avg Revenue beat(8)-1.08%
Revenue beat(12)4
Avg Revenue beat(12)-0.78%
Revenue beat(16)8
Avg Revenue beat(16)0.02%
PT rev (1m)-2.39%
PT rev (3m)-1.21%
EPS NQ rev (1m)3.27%
EPS NQ rev (3m)4.69%
EPS NY rev (1m)-2.55%
EPS NY rev (3m)-2.15%
Revenue NQ rev (1m)0.08%
Revenue NQ rev (3m)0.72%
Revenue NY rev (1m)0.1%
Revenue NY rev (3m)0.97%
Valuation
Industry RankSector Rank
PE 42.7
Fwd PE 32.82
P/S 6.53
P/FCF 34.27
P/OCF 33.09
P/B 6.48
P/tB 18.7
EV/EBITDA 48.25
EPS(TTM)1.69
EY2.34%
EPS(NY)2.2
Fwd EY3.05%
FCF(TTM)2.11
FCFY2.92%
OCF(TTM)2.18
OCFY3.02%
SpS11.05
BVpS11.14
TBVpS3.86
PEG (NY)6.76
PEG (5Y)0.89
Graham Number20.58
Profitability
Industry RankSector Rank
ROA 6.4%
ROE 9.72%
ROCE 8.73%
ROIC 7.91%
ROICexc 10.35%
ROICexgc 46.15%
OM 9.71%
PM (TTM) 9.79%
GM 61.67%
FCFM 19.05%
ROA(3y)11.61%
ROA(5y)4.91%
ROE(3y)17.82%
ROE(5y)7.29%
ROIC(3y)7.16%
ROIC(5y)N/A
ROICexc(3y)15.95%
ROICexc(5y)N/A
ROICexgc(3y)439.05%
ROICexgc(5y)N/A
ROCE(3y)7.91%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-16.81%
ROICexc growth 5YN/A
OM growth 3Y22.98%
OM growth 5YN/A
PM growth 3Y43.88%
PM growth 5YN/A
GM growth 3Y-0.01%
GM growth 5Y4.37%
F-Score7
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 20.82%
Cap/Sales 0.68%
Interest Coverage 250
Cash Conversion 151.93%
Profit Quality 194.56%
Current Ratio 1.31
Quick Ratio 1.25
Altman-Z 9.03
F-Score7
WACC10.91%
ROIC/WACC0.73
Cap/Depr(3y)131.65%
Cap/Depr(5y)90.98%
Cap/Sales(3y)2.69%
Cap/Sales(5y)1.97%
Profit Quality(3y)162.49%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.12%
EPS 3Y23.91%
EPS 5Y47.96%
EPS Q2Q%10.53%
EPS Next Y6.32%
EPS Next 2Y18.73%
EPS Next 3Y21.38%
EPS Next 5YN/A
Revenue 1Y (TTM)17.86%
Revenue growth 3Y19.23%
Revenue growth 5Y11.38%
Sales Q2Q%15.57%
Revenue Next Year16.54%
Revenue Next 2Y15.44%
Revenue Next 3Y15.02%
Revenue Next 5Y21.76%
EBIT growth 1Y16.97%
EBIT growth 3Y46.64%
EBIT growth 5YN/A
EBIT Next Year197.99%
EBIT Next 3Y68.08%
EBIT Next 5Y56.79%
FCF growth 1Y147.44%
FCF growth 3Y24.23%
FCF growth 5Y48.7%
OCF growth 1Y74.29%
OCF growth 3Y24.6%
OCF growth 5Y39.06%

AGILYSYS INC / AGYS FAQ

Can you provide the ChartMill fundamental rating for AGILYSYS INC?

ChartMill assigns a fundamental rating of 6 / 10 to AGYS.


What is the valuation status for AGYS stock?

ChartMill assigns a valuation rating of 3 / 10 to AGILYSYS INC (AGYS). This can be considered as Overvalued.


Can you provide the profitability details for AGILYSYS INC?

AGILYSYS INC (AGYS) has a profitability rating of 7 / 10.


How financially healthy is AGILYSYS INC?

The financial health rating of AGILYSYS INC (AGYS) is 6 / 10.


Can you provide the expected EPS growth for AGYS stock?

The Earnings per Share (EPS) of AGILYSYS INC (AGYS) is expected to grow by 6.32% in the next year.